ImageneBio

IMANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$46.200 M

$4.07 -0.73%

Close of 6 Nov 2026

As of 6 Nov 2026, ImageneBio (IMA) has a market capitalization of $46.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$800.0K

#3477 by revenue

Earnings

-$45.3M

Loss-making

Shares outstanding

11,351,456

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#125Greenland MinesGRML$49.3M
#126Instil BioTIL$47.9M
#127ImageneBioIMA$46.2M
#128Caribou BiosciencesCRBU$44.2M
#129LeonaBioLONA$40.8M

What if ImageneBio were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,487,511

Per share 611,182× higher

Bitcoin $1.53T

$134,594.90

Per share 33,070× higher

Apple $5.02T

$441,862.49

Per share 108,566× higher

Or at a round number

$100.0M $200.0M $500.0M $1.00B

Where these numbers come from

Share counts and financials for ImageneBio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.